Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04022109 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing Approach

Study acronym: VOGAS
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 26, 2021 (before its estimated December 2022 completion). Its status may not reflect the trial's current state.

Record History

  1. Re-verified, no change to tracked fieldsv4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Dec 2021 to Dec 2022
    • Start date changed from estimate of Aug 2019 to Nov 1, 2019
    • Site details revised at 5 of 5 sites
    v3
  3. Study Status, Eligibilityv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study is aimed to determine the potential of volatile marker testing for gastric cancer screening. The study will be addressing the role of confounding factors, including lifestyle factors, diet, smoking as well as addressing the potential role of microbiota in the composition of exhaled volatile markers.
Trial Details
NCT Number NCT04022109
Lead Sponsor University of Latvia
Collaborators: Technion, Israel Institute of Technology, University of Ulm, Uppsala University, JLM Innovation GmbH, Universitaet Innsbruck, Hospital Universitario San Ignacio, Universidad de Pamplona, Pontificia Universidad Catolica de Chile, AC Camargo Cancer Center, National Cancer Institute of Ukraine, VTT Technical Research Centre of Finland
Conditions
(from sponsor)		 Gastric Cancer, Atrophic Gastritis, Gastric Dysplasia, H.Pylori Infection
Related terms Gastritis, Atrophic, Stomach Neoplasms
Enrollment 5,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov